Literature DB >> 16718776

Cellular and molecular aspects of gastric cancer.

Malcolm-G Smith1, Georgina-L Hold, Eiichi Tahara, Emad-M El-Omar.   

Abstract

Gastric cancer remains a global killer with a shifting burden from the developed to the developing world. The cancer develops along a multistage process that is defined by distinct histological and pathophysiological phases. Several genetic and epigenetic alterations mediate the transition from one stage to another and these include mutations in oncogenes, tumour suppressor genes and cell cycle and mismatch repair genes. The most significant advance in the fight against gastric cancer came with the recognition of the role of Helicobacter pylori (H pylori) as the most important acquired aetiological agent for this cancer. Recent work has focussed on elucidating the complex host/microbial interactions that underlie the neoplastic process. There is now considerable insight into the pathogenesis of this cancer and the prospect of preventing and eradicating the disease has become a reality. Perhaps more importantly, the study of H pylori-induced gastric carcinogenesis offers a paradigm for understanding more complex human cancers. In this review, we examine the molecular and cellular events that underlie H pylori-induced gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718776      PMCID: PMC4124370          DOI: 10.3748/wjg.v12.i19.2979

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  150 in total

Review 1.  Oncogenic potential of the RUNX gene family: 'overview'.

Authors:  Yoshiaki Ito
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

2.  Tumor production in the glandular stomach and alimentary tract of the rat by N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  T Sugimura; S Fujimura; T Baba
Journal:  Cancer Res       Date:  1970-02       Impact factor: 12.701

3.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.

Authors:  P Masiakowski; R Breathnach; J Bloch; F Gannon; A Krust; P Chambon
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

4.  Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors.

Authors:  K Yoshida; J Bolodeoku; T Sugino; S Goodison; Y Matsumura; B F Warren; T Toge; E Tahara; D Tarin
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

5.  Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection.

Authors:  R Rad; A Dossumbekova; B Neu; R Lang; S Bauer; D Saur; M Gerhard; C Prinz
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 6.  Genetic pathways of two types of gastric cancer.

Authors:  Eiichi Tahara
Journal:  IARC Sci Publ       Date:  2004

7.  Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population.

Authors:  Sharon A Savage; Christian C Abnet; Kashif Haque; Steven D Mark; You-Lin Qiao; Zhi-Wei Dong; Sanford M Dawsey; Philip R Taylor; Stephen J Chanock
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-09       Impact factor: 4.254

8.  Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma.

Authors:  Tai Young Kim; Hyeon Joo Lee; Kyu Sang Hwang; Minjin Lee; Jae Won Kim; Yung-Jue Bang; Gyeong Hoon Kang
Journal:  Lab Invest       Date:  2004-04       Impact factor: 5.662

9.  Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases.

Authors:  K H Lee; J S Lee; C Suh; S W Kim; S B Kim; J H Lee; M S Lee; M Y Park; H S Sun; S H Kim
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

10.  Kinetics of nitrosamide formation from alkylureas, N-alkylurethans, and alkylguanidines: possible implications for the etiology of human gastric cancer.

Authors:  S S Mirvish
Journal:  J Natl Cancer Inst       Date:  1971-06       Impact factor: 13.506

View more
  89 in total

1.  (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.

Authors:  Bao-He Zhu; Hua-Yun Chen; Wen-Hua Zhan; Cheng-You Wang; Shi-Rong Cai; Zhao Wang; Chang-Hua Zhang; Yu-Long He
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

2.  Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells.

Authors:  Wen-Xia Kuai; Qiong Wang; Xiao-Zhong Yang; Yao Zhao; Ren Yu; Xiao-Jun Tang
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

3.  Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis.

Authors:  Kaushik Mukherjee; Dunfa Peng; Zaid Brifkani; Abbes Belkhiri; Manuel Pera; Tatsuki Koyama; Elizabeth A S Koehler; Frank L Revetta; Mary K Washington; Wael El-Rifai
Journal:  Surgery       Date:  2010-07-01       Impact factor: 3.982

4.  MAD1 (mitotic arrest deficiency 1) is a candidate for a tumor suppressor gene in human stomach.

Authors:  Mitsuhiko Osaki; Toshiaki Inoue; Shigeyuki Yamaguchi; Aiko Inaba; Naruo Tokuyasu; Kuan-Teh Jeang; Mitsuo Oshimura; Hisao Ito
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

Review 5.  Molecular inflammation: underpinnings of aging and age-related diseases.

Authors:  Hae Young Chung; Matteo Cesari; Stephen Anton; Emanuele Marzetti; Silvia Giovannini; Arnold Young Seo; Christy Carter; Byung Pal Yu; Christiaan Leeuwenburgh
Journal:  Ageing Res Rev       Date:  2008-07-18       Impact factor: 10.895

Review 6.  Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Authors:  Aline Cristina Targa Cadamuro; Ana Flávia Teixeira Rossi; Nathália Maciel Maniezzo; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

7.  Comparative genomic study of gastric epithelial cells co-cultured with Helicobacter pylori.

Authors:  Fen Wang; Li-Dan Luo; Jian-Hua Pan; Li-Hua Huang; Hong-Wei Lv; Qin Guo; Can-Xia Xu; Shou-Rong Shen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 8.  Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.

Authors:  Hasan Raza Kazmi; Soni Kumari; Satendra Tiwari; A Khanna; Gopeshwar Narayan
Journal:  Pathol Oncol Res       Date:  2018-03-19       Impact factor: 3.201

9.  S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells.

Authors:  Chae Hwa Kwon; Hyun Jung Moon; Hye Ji Park; Jin Hwa Choi; Do Youn Park
Journal:  Mol Cells       Date:  2013-02-26       Impact factor: 5.034

10.  L-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients' survival with stomach adenocarcinomas.

Authors:  Dimitra Florou; Iordanis N Papadopoulos; Emmanuel G Fragoulis; Andreas Scorilas
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.